AstraZeneca Plc (AZN):企業のM&A・提携動向(医療機器分野)

◆英語タイトル:AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME3904D
◆発行会社(調査会社):GlobalData
◆発行日:2017年2月14日
◆ページ数:117
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:英国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory, inflammation, autoimmune disease (RIA); cardiovascular and metabolic disease (CVMD); and cancer, besides infection and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies and through distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in London, the UK.

AstraZeneca Plc (AZN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
AstraZeneca Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
AstraZeneca Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 10
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
AstraZeneca Plc, Medical Equipment, Deal Details 14
Venture Financing 14
Definiens Raises USD20.3 Million in Venture Financing Round 14
CeraPedics Raises US$19 Million In Series C Financing 15
Definiens Raises US$13 Million In Venture Financing 16
Ambit Biosciences Secures US$30 Million In Series D-2 Financing 17
Partnerships 19
AstraZeneca Enters into Agreement with Genedata 19
Neoprobe Enters Into Licensing Agreement With AstraZeneca 20
AgPlus Diagnostics Enters into Agreement with AstraZeneca 21
Indivumed Partners with Definiens 22
Foundation Medicine Enters into Agreement with AstraZeneca 23
MedImmune Enters into Agreement with Genisphere 23
Definiens Partners with MolecularMD 24
Human Longevity Partners with AstraZeneca 25
PROOF Centre Partners with AstraZeneca 26
Labcyte Enters into Agreement with AstraZeneca 26
HighRes Biosolutions Enters into Agreement with AstraZeneca 27
AstraZeneca Enters into Research Agreement with Sutter Health 28
Myriad Genetics Expands Agreement with AstraZeneca 29
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 30
AstraZeneca Enters into Co-Development Agreement with Qiagen 31
AstraZeneca Enters into Co-Development Agreement with Roche 32
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 32
Ventana Medical Enters into Co-Development Agreement with MedImmune 33
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 34
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 35
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 36
AstraZeneca Enters Into Research Agreement With Karolinska Institutet 36
Metamark Genetics Enters Into Co-Development Agreement With Definiens 37
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 38
Leica Microsystems Enters Into Co-Marketing Agreement With Definiens 39
Definiens Enters Into An Agreement With Cernostics 40
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 41
Merger 42
AstraZeneca Rumored To Merge With Amgen 42
Debt Offering 43
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 43
Acquisition 43
Pfizer May Increase Bid to Acquire AstraZeneca 43
MedImmune Acquires Definiens for USD150 Million 45
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion 46
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 47
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 48
DENTSPLY International Acquires Astra Tech From AstraZeneca For US$1,800 Million 49
AstraZeneca Plc – Key Competitors 52
Key Employees 53
Locations And Subsidiaries 55
Head Office 55
Other Locations & Subsidiaries 55
Recent Developments 61
Strategy And Business Planning 61
Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery 61
Financial Announcements 62
Feb 02, 2017: Astrazeneca Announces Full-Year and Q4 2016 Results 62
Nov 10, 2016: AstraZeneca: Year-To-Date and Q3 2016 Results 63
Jul 28, 2016: AstraZeneca: H1 2016 Results 75
Apr 29, 2016: AstraZeneca announces 1st Quarter 2016 Results 86
Apr 29, 2016: AstraZeneca Announces Q1 2016 Results 97
Feb 04, 2016: Full-Year and Q4 2015 Results 99
Feb 04, 2016: AstraZeneca Full-Year and Q4 2015 Results 101
Corporate Communications 114
Nov 09, 2016: Change To Astrazeneca Board Of Directors 114
Sep 28, 2016: Change To Astrazeneca Board Of Directors 115
Other Significant Developments 116
Sep 21, 2016: AstraZeneca Selects LLamasoft as Supply Chain Design Partner of Choice 116
Appendix 117
Methodology 117
About GlobalData 117
Contact Us 117
Disclaimer 117

List of Tables
AstraZeneca Plc, Medical Equipment, Key Facts, 2015 1
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
AstraZeneca Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
AstraZeneca Plc, Deals By Market, 2011 to YTD 2017 10
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Definiens Raises USD20.3 Million in Venture Financing Round 14
CeraPedics Raises US$19 Million In Series C Financing 15
Definiens Raises US$13 Million In Venture Financing 16
Ambit Biosciences Secures US$30 Million In Series D-2 Financing 17
AstraZeneca Enters into Agreement with Genedata 19
Neoprobe Enters Into Licensing Agreement With AstraZeneca 20
AgPlus Diagnostics Enters into Agreement with AstraZeneca 21
Indivumed Partners with Definiens 22
Foundation Medicine Enters into Agreement with AstraZeneca 23
MedImmune Enters into Agreement with Genisphere 23
Definiens Partners with MolecularMD 24
Human Longevity Partners with AstraZeneca 25
PROOF Centre Partners with AstraZeneca 26
Labcyte Enters into Agreement with AstraZeneca 26
HighRes Biosolutions Enters into Agreement with AstraZeneca 27
AstraZeneca Enters into Research Agreement with Sutter Health 28
Myriad Genetics Expands Agreement with AstraZeneca 29
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 30
AstraZeneca Enters into Co-Development Agreement with Qiagen 31
AstraZeneca Enters into Co-Development Agreement with Roche 32
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 32
Ventana Medical Enters into Co-Development Agreement with MedImmune 33
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 34
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 35
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 36
AstraZeneca Enters Into Research Agreement With Karolinska Institutet 36
Metamark Genetics Enters Into Co-Development Agreement With Definiens 37
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 38
Leica Microsystems Enters Into Co-Marketing Agreement With Definiens 39
Definiens Enters Into An Agreement With Cernostics 40
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 41
AstraZeneca Rumored To Merge With Amgen 42
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 43
Pfizer May Increase Bid to Acquire AstraZeneca 43
MedImmune Acquires Definiens for USD150 Million 45
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion 46
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 47
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 48
DENTSPLY International Acquires Astra Tech From AstraZeneca For US$1,800 Million 49
AstraZeneca Plc, Key Competitors 52
AstraZeneca Plc, Key Employees 53
AstraZeneca Plc, Subsidiaries 55

List of Figures
AstraZeneca Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
AstraZeneca Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
AstraZeneca Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 10

★海外企業調査レポート[AstraZeneca Plc (AZN):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suzhou Thvow Technology Co., Ltd. (002564):企業財務及び戦略的SWOT分析
    Summary Suzhou Thvow Technology Co., Ltd. (Suzhou Technology), formerly Zhangjiagang Chemical Machinery Co., Ltd. is an industrial equipment company that provides vessel products. The company offers products including vessels, EPC systems, heat exchangers, boilers, special materials, head equipment …
  • Golden Queen Mining Co. Ltd.:企業の戦略・SWOT・財務分析
    SummaryGolden Queen Mining Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Honeywell Aerospace:企業の戦略・SWOT・財務分析
    SummaryHoneywell Aerospace - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Aeronautics Defense Systems, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Aeronautics Defense Systems, Lt …
  • 3Power Energy Group (formerly Prime Sun Power, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' 3Power Energy Group (formerly P …
  • INTL FCStone Inc:戦略・SWOT・企業財務分析
    INTL FCStone Inc - Strategy, SWOT and Corporate Finance Report Summary INTL FCStone Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Karnataka Power Corporation Limited:企業の戦略的SWOT分析
    Summary Karnataka Power Corporation Limited (KPCL) is a state-owned electricity generating company. It generates and distributes electricity across the state of Karnataka, India. Its power generation portfolio comprises hydro, solar, thermal and wind energy power plants. KPCL operates around 34 dams …
  • BioSyent Inc. (RX):企業の財務及び戦略的SWOT分析
    Summary BioSyent Inc. (BioSyent) is a pharmaceutical company that concentrates on the acquisition and in-licensing of products, and marketing of technologies to enhance human health. The company's products include Aguettant System for pre-filled syringes; Cathejell Jelly; FeraMAX 150, an oral hemati …
  • Cape Lambert Iron Ore Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cape Lambert Iron Ore Limited M …
  • Vitol Group:企業の戦略・SWOT・財務分析
    Vitol Group - Strategy, SWOT and Corporate Finance Report Summary Vitol Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Apricus Biosciences Inc (APRI):企業のM&A・提携動向(医療機器分野)
    Summary Apricus Biosciences Inc (Apricus) develops and commercializes pharmaceutical products indicated for the treatment of various therapeutic classes including male and female sexual health. Its commercial product portfolio includes, Vitaros, a vasodilator to treat erectile dysfunction. Apricus' …
  • Diazyme Laboratories Inc:製品パイプライン分析
    Summary Diazyme Laboratories Inc (Diazyme Laboratories) is a developer of diagnostic reagents. The company’s products include vitamin D assays, vitamin D assay for clinical chemistry analyzers, adenosine deaminase assay, cardiac troponin I assay, creatinine assay, D-dimer assay, direct enzymatic HbA …
  • Banco Popular Espanol, S.A.:戦略・SWOT・企業財務分析
    Banco Popular Espanol, S.A. - Strategy, SWOT and Corporate Finance Report Summary Banco Popular Espanol, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Dil Ltd. (506414):企業概要、財務及び戦略的SWOT分析
    Summary Dil Ltd. (Dil) is a biotechnology company. The company develops and manufactures enzymes, vitamin D3 and other bulk drugs. It offers enzyme mediated asymmetric synthesis of hydroxyesters, heterocycles, protection of amino acids at amino and carboxyl functionalities, and synthesis of compound …
  • Hansen Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Health Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products comprise robotic system, robotic catheters, s …
  • Cherry Bekaert LLP (formerly Cherry, Bekaert and Holland, L.L.P.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cherry Bekaert LLP (formerly Ch …
  • Fujirebio Diagnostics, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Fujirebio Diagnostics, Inc. (FDI), a subsidiary of Fujirebio, Inc. is a healthcare diagnostic company that develops, manufactures and markets in-vitro diagnostic products and biomarker assays for the management of human disease states. The company products include manual kits, EIA kits, othe …
  • JSC “Arhenergosbyt”:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JSC "Arhenergosbyt" Mergers and …
  • Societe Generale S.A.:企業の戦略・SWOT・財務分析
    SummarySociete Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Black Hills Power, Inc.:企業のM&A・提携動向(エネルギー分野)
    Summary Black Hills Energy (BHE), formerly Black Hills Power, Inc. is a subsidiary of Black Hills Corporation, power company that provides utility services. The company offers products such as wholesale electricity, natural gas, oil and coal. It provides services including electricity and natural ga …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆